Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Srivasa B. Chebrolu"'
Publikováno v:
The International Journal of Artificial Organs. 28:270-274
Severe methanol poisoning requires treatment with prolonged and intensive hemodialytic therapy. Such treatment can engender either the de novo development of hypophosphatemia or the worsening of pre-existing hypophosphatemia. Phosphorus-enriched hemo
Autor:
Alex W.Y. Yu, Peter Choi, Srivasa B. Chebrolu, Yuk Lun Cheng, Todd S. Ing, Carl M. Kjellstrand
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 7(2)
Although hyperphosphatemia is a cardinal feature of renal failure, the occasional patient suffering from end-stage renal disease (ESRD) may present with hypophosphatemia. For example, hypophosphatemia can develop in ESRD patients if they suffer from
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 8(1)
Autor:
Tarek M. Daoud, Almothana Shanaah, David J. Leehey, Srivasa B. Chebrolu, Todd S. Ing, Erlandas Ulozas
Publikováno v:
Artificial organs. 28(2)
Hemodialysis using a bath with less-than-normal calcium level can cause hypocalcemia. The development of symptomatic hypocalcemia with resultant hypotension after the inadvertent use of a calcium-free dialysate in a maintenance hemodialysis patient i
Autor:
Vasant C. Gandhi, Barbara G. Delano, George Ting, Zbylut J. Twardowski, Todd S. Ing, Yalem W. Woredekal, Christopher R. Blagg, Srivasa B. Chebrolu, C.M. Kjellstrand, Amy W. Williams
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 43(1)
Background: Advantages associated with an increased frequency of hemodialysis have been reported previously. However, previous studies were either small or not controlled and did not detail early clinical, biochemical, quality-of-life, urea kinetic,
Publikováno v:
Hemodialysis International. 8:2-3